MedTrace Logo

Observational Follow up of Prior HPV Vaccinees

NCT02811068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2019-03-26

No results posted yet for this study

Summary

HPV vaccines have been included in the national immunisation schedule since 2008, firstly as the Cervarix vaccine which protects against two HPV types and in 2012 as the Gardasil vaccine which offers protection against a further two HPV types. This study will assess whether booster doses are indicated to protect females throughout their lifetime or if the vaccinations offered in early adolescence provide this by following up a cohort from a previous study where female adolescents were vaccinated 5-7 years ago.

Conditions

  • Human Papillomavirus Virus

Interventions

OTHER

venepuncture

single venepuncture

Sponsors & Collaborators

  • Public Health England

    lead OTHER_GOV

Principal Investigators

  • Elizabeth Coates · Public Health England

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02811068 on ClinicalTrials.gov